Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Biomarkers in Moderate to Severe Pediatric Traumatic Brain Injury: A Review of the Literature.

Tytuł:
Biomarkers in Moderate to Severe Pediatric Traumatic Brain Injury: A Review of the Literature.
Autorzy:
Munoz Pareja JC; Division of Pediatric Critical Care, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: .
Li X; Department of Pediatrics, Sixth People's Hospital/Occupational Disease Prevention Hospital, Nan'an District, Chongqing, China; Program for Neurotrauma, Neuroproteomics and Biomarkers Research, Department of Emergency Medicine, University of Florida, Gainesville, Florida; Department of Emergency Medicine, Program for Neurotrauma, Neuroproteomics & Biomarker Research, McKnight Brain Institute, University of Florida, Gainesville, Florida.
Gandham N; Department of Emergency Medicine, Program for Neurotrauma, Neuroproteomics & Biomarker Research, McKnight Brain Institute, University of Florida, Gainesville, Florida.
Wang KK; Department of Emergency Medicine, Program for Neurotrauma, Neuroproteomics & Biomarker Research, McKnight Brain Institute, University of Florida, Gainesville, Florida; Brain Rehabilitation Research Center, Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida.
Corporate Authors:
Pediatric TBI Workgroup
Źródło:
Pediatric neurology [Pediatr Neurol] 2022 May; Vol. 130, pp. 60-68. Date of Electronic Publication: 2022 Mar 18.
Typ publikacji:
Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: New York Ny : Elsevier Science Publishing
Original Publication: Chippewa Falls, Wis. : Professional Publications, [c1985-
MeSH Terms:
Brain Injuries*
Brain Injuries, Traumatic*/diagnosis
Biomarkers ; Brain ; Child ; Humans ; Prognosis
References:
J Neurotrauma. 2018 Jan 1;35(1):64-72. (PMID: 28762893)
Neurosurgery. 2019 Jun 1;84(6):1169-1178. (PMID: 30822776)
Pediatrics. 2006 Feb;117(2):325-32. (PMID: 16452350)
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):161-2. (PMID: 14707332)
Pediatrics. 2002 Feb;109(2):E31. (PMID: 11826241)
Nat Rev Neurol. 2018 Oct;14(10):577-589. (PMID: 30171200)
Clin Chem Lab Med. 2005;43(11):1215-7. (PMID: 16232088)
Clin Biochem. 2011 Jul;44(10-11):927-9. (PMID: 21601568)
Mol Cell. 2014 Mar 20;53(6):1031-1043. (PMID: 24631284)
Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. (PMID: 29338452)
J Trauma. 2010 May;68(5):1072-7. (PMID: 20453761)
Childs Nerv Syst. 2010 Feb;26(2):205-13. (PMID: 19902222)
Dev Neurosci. 2010;32(5-6):396-405. (PMID: 20847541)
Pediatrics. 2018 Jun;141(6):. (PMID: 29716980)
J Neurotrauma. 2021 Apr 15;38(8):1151-1163. (PMID: 31880977)
J Neurosurg Pediatr. 2018 Oct;22(4):369-374. (PMID: 29957142)
World Neurosurg. 2018 Oct;118:e534-e542. (PMID: 30257306)
Intensive Care Med. 2003 Aug;29(8):1329-38. (PMID: 12845427)
J Neurotrauma. 2016 Jan 15;33(2):215-25. (PMID: 26159676)
J Neurotrauma. 2007 Jan;24(1):97-105. (PMID: 17263673)
Dev Neurosci. 2006;28(4-5):327-35. (PMID: 16943655)
Lancet Child Adolesc Health. 2019 Aug;3(8):558-567. (PMID: 31231066)
Clin Chem Lab Med. 2015 Sep 1;53(10):1575-84. (PMID: 25720124)
Neurosurgery. 2001 Jun;48(6):1255-8; discussion 1258-60. (PMID: 11383727)
Neurocrit Care. 2014 Jun;20(3):427-35. (PMID: 23943317)
Pediatr Crit Care Med. 2011 May;12(3):319-24. (PMID: 20625342)
Shock. 2014 Jun;41(6):499-503. (PMID: 24667615)
Neurocrit Care. 2012 Dec;17(3):401-7. (PMID: 22890910)
Lancet. 1974 Jul 13;2(7872):81-4. (PMID: 4136544)
Brain Inj. 2012;26(11):1372-80. (PMID: 22725661)
Neurosurgery. 2012 Mar;70(3):666-75. (PMID: 21937927)
Shock. 2015 Nov;44(5):410-6. (PMID: 26196846)
Shock. 2005 Aug;24(2):119-23. (PMID: 16044081)
Sports Med Arthrosc Rev. 2016 Sep;24(3):e42-52. (PMID: 27482782)
J Head Trauma Rehabil. 2005 May-Jun;20(3):189-95. (PMID: 15908819)
J Neurotrauma. 2016 Jul 1;33(13):1270-7. (PMID: 26560343)
Allergy. 2018 Jul;73(7):1393-1414. (PMID: 29336054)
J Neurotrauma. 2007 Dec;24(12):1793-801. (PMID: 18159990)
Brain Res. 2002 Aug 23;947(1):131-9. (PMID: 12144861)
J Cereb Blood Flow Metab. 2020 Jan;40(1):35-43. (PMID: 30866741)
World Neurosurg. 2014 Jan;81(1):151-8. (PMID: 23313262)
Sci Rep. 2016 Jun 20;6:28203. (PMID: 27319802)
J Trauma. 2005 Jan;58(1):59-61. (PMID: 15674151)
Acta Paediatr. 2015 May;104(5):479-84. (PMID: 25619878)
Neurocrit Care. 2004;1(4):479-88. (PMID: 16174954)
Front Neurol. 2017 Jul 20;8:351. (PMID: 28775710)
Acta Neurochir (Wien). 2012 Jan;154(1):93-103; discussion 103. (PMID: 21976236)
J Exp Neurosci. 2019 Mar 08;13:1179069519832286. (PMID: 30886525)
J Neurotrauma. 2007 Jan;24(1):75-86. (PMID: 17263671)
PLoS Genet. 2014 Oct 02;10(10):e1004626. (PMID: 25275521)
Brain Inj. 2016;30(10):1231-8. (PMID: 27416022)
J Head Trauma Rehabil. 2005 May-Jun;20(3):187-8. (PMID: 15908818)
J Neurotrauma. 2016 Jan 1;33(1):58-64. (PMID: 25752485)
Front Neurol. 2015 Mar 30;6:68. (PMID: 25870583)
Ther Innov Regul Sci. 2015 Sep;49(5):666-672. (PMID: 30227036)
Scand J Clin Lab Invest. 1998 May;58(3):183-6. (PMID: 9670341)
J Neurotrauma. 2016 Apr 1;33(7):688-95. (PMID: 26414158)
Clin Chem Lab Med. 2010 Jun;48(6):891-2. (PMID: 20345234)
Front Neurol. 2017 Jul 03;8:300. (PMID: 28717351)
Medicine (Baltimore). 2019 Nov;98(44):e17806. (PMID: 31689863)
Front Neurol. 2015 May 26;6:110. (PMID: 26074866)
J Neurotrauma. 2012 Jan 1;29(1):162-7. (PMID: 22022780)
Front Neurol. 2017 Dec 04;8:652. (PMID: 29255443)
Brain Imaging Behav. 2021 Apr;15(2):555-575. (PMID: 32734437)
Childs Nerv Syst. 2019 Feb;35(2):343-348. (PMID: 30171330)
J Neurotrauma. 2016 Oct 1;33(19):1784-1789. (PMID: 26700106)
Clin Chem. 2002 Jun;48(6 Pt 1):950-2. (PMID: 12029017)
Eur J Paediatr Neurol. 2008 May;12(3):195-204. (PMID: 17881264)
Brain Behav Immun. 2015 Mar;45:253-62. (PMID: 25555531)
Neurology. 2017 Feb 7;88(6):595-602. (PMID: 28062722)
World J Pediatr. 2015 Nov;11(4):309-15. (PMID: 26454435)
Pediatrics. 2009 Oct;124(4):e697-704. (PMID: 19786430)
Pediatr Crit Care Med. 2016 Jul;17(7):638-48. (PMID: 27167007)
J Neurotrauma. 2002 Nov;19(11):1405-9. (PMID: 12490005)
Brain Behav Immun. 2016 Mar;53:183-193. (PMID: 26705843)
Grant Information:
U01 NS086090 United States NS NINDS NIH HHS
Contributed Indexing:
Investigator: L Lautenslager, Division of Pediatric Critical Care, Department of Pediatrics, University of Florida, Gainesville, Florida.; MC Pareja, Fundación Universitaria Sanitas, Bogotá, Colombia.; P Shanmugham, Division of Pediatric Critical Care, Department of Pediatrics, University of Florida, Gainesville, Florida.; S Faulkinberry, Division of Pediatric Critical Care, Department of Pediatrics, University of Florida, Gainesville, Florida.; S Ghosh, Department of Pediatric Neurology, University of Florida, Gainesville, Florida.; M Kerrigan, Louisiana State University School of Medicine, Shreveport, Louisiana.; MR Kashyap, Division of Pediatric Critical Care, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida.
Keywords: Biomarkers; Diagnostics; Pediatrics; Traumatic brain injury
Substance Nomenclature:
0 (Biomarkers)
Entry Date(s):
Date Created: 20220401 Date Completed: 20220426 Latest Revision: 20230502
Update Code:
20240104
PubMed Central ID:
PMC9038667
DOI:
10.1016/j.pediatrneurol.2022.03.002
PMID:
35364462
Czasopismo naukowe
Background: Despite decades of research, outcomes in pediatric traumatic brain injury (pTBI) remain highly variable. Brain biofluid-specific biomarkers from pTBI patients may allow us to diagnose and prognosticate earlier and with a greater degree of accuracy than conventional methods. This manuscript reviews the evidence surrounding current brain-specific biomarkers in pTBI and assesses the temporal relationship between the natural history of the traumatic brain injury (TBI) and measured biomarker levels.
Methods: A literature search was conducted in the Ovid, PubMed, MEDLINE, and Cochrane databases seeking relevant publications. The study selection and screening process were documented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. Extraction forms included developmental stages of patients, type and biofluid source of biomarkers, brain injury type, and other relevant data.
Results: The search strategy identified 443 articles, of which 150 examining the biomarkers of our interest were included. The references retrieved were examined thoroughly and discussed at length with a pediatric neurocritical care intensivist specializing in pTBI and a Ph.D. scientist with a high degree of involvement in TBI biomarker research, authoring a vast amount of literature in this field.
Conclusions: TBI biomarkers might serve as valuable tools in the diagnosis and prognosis of pTBI. However, while each biomarker has its advantages, they are not without limitations, and therefore, further research is critical in pTBI biomarkers.
(Copyright © 2022 Elsevier Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies